• 0 Citations
  • 0 h-Index
20192019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Massimo Siciliano is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 47 Similar Profiles
Ribavirin Medicine & Life Sciences
Hepatitis C Medicine & Life Sciences
Fibrosis Medicine & Life Sciences
Genotype Medicine & Life Sciences
Gastroenterology Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Hepacivirus Medicine & Life Sciences
Antiviral Agents Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2019 2019

Daclatasvir, sofosbuvir with or without ribavirin for 24 weeks in hepatitis C genotype 3 cirrhosis: A real-life study

Lionetti, R., Piccolo, P., Lenci, I., Siciliano, M., Visco-Comandini, U., De Santis, A., Pompili, M., Milana, M., Taibi, C., Dell'Isola, S., Montalbano, M., Mastroianni, C., Begini, P., Garbuglia, A. R., Angelico, M. & D'Offizi, G., May 1 2019, In : Annals of Hepatology. 18, 3, p. 434-438 5 p.

Research output: Contribution to journalArticle

Open Access
Ribavirin
Hepatitis C
Fibrosis
Genotype
Gastroenterology